<SEC-DOCUMENT>0001171843-20-005862-index.html : 20200812 <SEC-HEADER>0001171843-20-005862.hdr.sgml : 20200812 <ACCEPTANCE-DATETIME>20200812163525 ACCESSION NUMBER: 0001171843-20-005862 CONFORMED SUBMISSION TYPE: S-8 PUBLIC DOCUMENT COUNT: 5 FILED AS OF DATE: 20200812 DATE AS OF CHANGE: 20200812 EFFECTIVENESS DATE: 20200812 FILER: COMPANY DATA: COMPANY CONFORMED NAME: BIOCRYST PHARMACEUTICALS INC CENTRAL INDEX KEY: 0000882796 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 621413174 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: S-8 SEC ACT: 1933 Act SEC FILE NUMBER: 333-245024 FILM NUMBER: 201095890 BUSINESS ADDRESS: STREET 1: 4505 EMPEROR BOULEVARD STREET 2: SUITE 200 CITY: DURHAM STATE: NC ZIP: 27703 BUSINESS PHONE: 919-859-1302 MAIL ADDRESS: STREET 1: 4505 EMPEROR BOULEVARD STREET 2: SUITE 200 CITY: DURHAM STATE: NC ZIP: 27703 </SEC-HEADER> <DOCUMENT> <TYPE>S-8 <SEQUENCE>1 <FILENAME>s8_081220.htm <DESCRIPTION>FORM S-8 <TEXT> Document 1 - file: s8_081220.htm
</DOCUMENT> <DOCUMENT> <TYPE>EX-5.1 <SEQUENCE>2 <FILENAME>exh_51.htm <DESCRIPTION>EXHIBIT 5.1 <TEXT> Document 2 - file: exh_51.htm
</DOCUMENT> <DOCUMENT> <TYPE>EX-23.1 <SEQUENCE>3 <FILENAME>exh_231.htm <DESCRIPTION>EXHIBIT 23.1 <TEXT> Document 3 - file: exh_231.htm
</DOCUMENT> <DOCUMENT> <TYPE>EX-99.1 <SEQUENCE>4 <FILENAME>exh_991.htm <DESCRIPTION>EXHIBIT 99.1 <TEXT> Document 4 - file: exh_991.htm
</DOCUMENT> <DOCUMENT> <TYPE>GRAPHIC <SEQUENCE>5 <FILENAME>footer.jpg <DESCRIPTION>GRAPHIC <TEXT> Document 5 - file: footer.jpg
</DOCUMENT> </SEC-DOCUMENT>